Additionally, mutations ( >15% frequency) in genes involved in KMT2D, ZFHX3, EP300, AHNAK2, and NOTCH1 had been identified, suggesting potential alternative drivers in SCLC pathogenesis (Supplementary Fig.2a). This evidence concerns the gene KMT2D and small cell lung carcinoma.